Mutual of America Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,956
| Closed | -$1.25M | – | 1497 |
|
|
2022
Q3 | $1.25M | Sell |
55,956
-5,095
| -8% | -$114K | 0.02% | 987 |
|
|
2022
Q2 | $1.51M | Sell |
61,051
-457
| -0.7% | -$11.3K | 0.02% | 971 |
|
|
2022
Q1 | $2.39M | Sell |
61,508
-2,673
| -4% | -$104K | 0.03% | 889 |
|
|
2021
Q4 | $3.76M | Sell |
64,181
-600
| -0.9% | -$35.1K | 0.04% | 711 |
|
|
2021
Q3 | $3.84M | Sell |
64,781
-935
| -1% | -$55.4K | 0.04% | 671 |
|
|
2021
Q2 | $5.7M | Buy |
65,716
+5,778
| +10% | +$501K | 0.06% | 454 |
|
|
2021
Q1 | $4.94M | Sell |
59,938
-3,314
| -5% | -$273K | 0.05% | 508 |
|
|
2020
Q4 | $5.75M | Sell |
63,252
-1,328
| -2% | -$121K | 0.07% | 391 |
|
|
2020
Q3 | $2.58M | Sell |
64,580
-11,050
| -15% | -$442K | 0.03% | 697 |
|
|
2020
Q2 | $2.6M | Buy |
+75,630
| New | +$2.6M | 0.04% | 704 |
|